We performed genome-wide CRISPR/Cas9 knockout screening in TB32047 cells, a murine cell line derived from a KPC model, to identify the genes that contribute to gemcitabine resistance. The top hits were sgRNAs for DCK and CCNL1. The inactivation of DCK and CCNL1 significantly increased the ...